Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Circulation|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV TrialVictorien Monguillon, Nicholas A Marston, Erin A Bohula, et al.
European Heart Journal|December 11, 2025
C-reactive protein and cardiovascular risk in the general populationBerkan Kurt, Martin Reugels, Kai M Schneider, et al.
Angiology|November 25, 2020
Short and Midterm Outcomes in Patients With Acute Myocardial Infarction: Results of the Nationwide TURKMI RegistryMustafa Kilickap, Mustafa Kemal Erol, Meral Kayikcioglu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
Atherosclerosis|April 10, 2024
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
Atherosclerosis. Supplements|May 21, 2014
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practiceNaveed A Sattar, Henry Ginsberg, Kausik Ray, et al.
Atherosclerosis|May 24, 2026
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinicsChristian Bork, Børge G Nordestgaard, Berit Storgaard Hedegaard, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
Pageof 18